ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
MWN-AI** Summary
ASP Isotopes Inc. (NASDAQ: ASPI) announced a significant partnership between its subsidiary, Quantum Leap Energy LLC (QLE), and the South African Nuclear Energy Corporation (Necsa) aimed at developing High Assay Low Enriched Uranium (HALEU) nuclear fuel. Signed on February 20, 2026, the Pre-Implementation Services Contract marks an important step toward enhancing global supply chains for next-generation fission reactors. This collaboration utilizes QLE’s proprietary enrichment technologies alongside Necsa’s renowned facilities, specifically at the Pelindaba site.
The agreement allows QLE to harness Necsa's established infrastructure to establish an enrichment facility, a crucial development given the rising demand for HALEU in advanced nuclear applications, including Small Modular Reactors (SMRs). The partnership solidifies QLE’s strategic objective to bring HALEU production to market readiness while adhering to necessary safety and regulatory standards as articulated by Necsa.
A Joint Coordination Committee has been established to oversee this initiative, suggesting a structured approach to collaboration. This partnership not only strengthens QLE’s operational capacity but also complements Necsa's strategic framework, which focuses on optimizing its fuel capabilities and expanding its global market reach.
As the urgency for clean, baseload power sources increases, this collaboration responds to urgent energy demands, with projections from the U.S. Department of Energy indicating a potential need for up to 500 metric tons of HALEU by 2050 to support the commercial nuclear industry.
Both Ryno Pretorius, CEO of QLE, and Loyiso Tyabashe, CEO of Necsa, expressed optimism regarding the partnership’s potential, emphasizing its alignment with broader strategic goals in the nuclear sector. This announcement positions both entities to play an influential role in advancing the nuclear energy landscape, addressing critical supply challenges in a rapidly evolving energy market.
MWN-AI** Analysis
The announcement from ASP Isotopes Inc. (NASDAQ: ASPI) regarding its strategic collaboration with the South African Nuclear Energy Corporation (Necsa) marks a pivotal moment for the nuclear fuel industry, particularly in high assay low enriched uranium (HALEU) production. This partnership advances QLE's goal to develop a reliable HALEU supply chain, crucial for the next generation of nuclear reactors, and aligns starkly with increasing global demand for sustainable and clean energy sources.
Investors should take note of several implications of this collaboration. Firstly, the forecasted surge in HALEU requirements, with the U.S. Department of Energy predicting demand to rise to 500 metric tons annually by 2050, presents a compelling growth opportunity for ASPI and QLE. The established infrastructure and expertise of Necsa could provide QLE with a competitive edge in meeting this demand, potentially enhancing shareholder value.
Secondly, ASPI's proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) technologies promise to address supply chain gaps in advanced nuclear applications. This innovative capacity positions QLE favorably in a niche market with high entry barriers, as it seeks to partner with various industry leaders like TerraPower and Fermi America.
Investors should also consider the geopolitical landscape surrounding nuclear energy. With countries increasingly looking towards nuclear power to meet aggressive climate targets, QLE's positioning in South Africa—a nation reconsolidating its energy strategy—could enhance its market relevance and attractiveness in international collaborations.
However, potential investors must remain cautious of the regulatory and operational risks associated with nuclear facilities. It is essential to monitor the developments of the service contract and any regulatory approvals required for the enrichment facility's construction and operation at Necsa’s Pelindaba site.
In conclusion, this collaboration embodies strategic foresight for QLE and ASPI, likely offering significant long-term growth. Investors may find ASPI a compelling opportunity but should stay vigilant regarding market trends, regulatory environments, and technological advancements that will influence the nuclear fuel landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Agreement between QLE’s South African subsidiary and Necsa related to the siting, design, construction, commission and operation of an enrichment facility on the Necsa site in Pelindaba, with QLE’s objective to achieve market readiness for production of nuclear fuel
The collaboration leverages QLE’s in-licensed and proprietary enrichment technology and Necsa’s globally-recognized production facilities
DALLAS, Feb. 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that on February 20, 2026, a South African subsidiary of Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, and the South African Nuclear Energy Corporation (“Necsa”) executed a Pre-Implementation Services Contract Agreement (“Services Contract”) as part of the planned collaboration on the research, development and ultimately commercial production of High Assay Low Enriched Uranium (HALEU), marking a critical step forward in addressing global nuclear fuel supply needs for next generation fission reactors.
Necsa’s mandate and expertise is in nuclear research and technology innovation and is amongst world leaders in nuclear technologies. The Services Contract builds on the previously announced MOU between ASPI’s South African subsidiary and Necsa, and leverages QLE's enrichment capabilities alongside Necsa's world-class capabilities and strategic positioning in the global nuclear value chain. Under the Services Contract, Necsa has agreed to provide to QLE’s South African subsidiary, Quantum Leap Energy (Pty) Ltd. (“QLE SA”), certain facilities, infrastructure, utilities and services related to the siting, design, construction, commission and operation of an enrichment facility on the Necsa site in Pelindaba. A Joint Coordination Committee, to be comprised of two representatives of QLE SA and Necsa, has been established to oversee and govern the implementation of the Services Contract.
QLE’s objective for the collaboration with Necsa is to achieve market readiness for HALEU production. The collaboration positions QLE to conduct research and development activities for enrichment operations at Necsa’s Pelindaba site, leveraging QLE's in-licensed and proprietary enrichment technology alongside Necsa's established nuclear infrastructure, subject to Necsa's prevailing site regulations, safety protocols and security requirements, and applicable National Nuclear Regulator (NNR) and other regulatory approvals. This initiative is in line with Necsa’s growth strategic framework of optimizing its nuclear fuel capabilities. The QLE-Necsa initiative represents an important step toward establishing diverse and reliable HALEU supply chains to support next-generation nuclear energy deployment.
“This milestone represents a significant advancement in our commercial partnership with Necsa and its proven infrastructure for the development of nuclear materials,” said Ryno Pretorius, CEO of Quantum Leap Energy. “Gaining access to this internationally-recognized facility is intended to help us to move from planning to implementation, and advance our goal of providing a reliable HALEU supply for next-generation reactors to meet rapidly growing market demand for HALEU nuclear fuel.”
"Necsa intends to optimize global networks of over 60 years and complementary capabilities on enrichment with QLE. Necsa is on a growth expansion trajectory and appreciates collaboration which opens more avenues for exploration and a broader market reach," said Loyiso Tyabashe, Necsa Group Chief Executive Officer. "Our extensive experience in nuclear technologies and established global distribution network positions this partnership to make a meaningful contribution to the emerging HALEU market."
This commercial partnership comes at a critical time as advanced reactor technologies requiring HALEU fuel are being developed globally at an accelerating pace to meet the clean, baseload power demands of AI data center infrastructure and industrial electrification. HALEU is a crucial fuel for small modular reactors (SMRs) and other advanced nuclear reactor designs. The United States Department of Energy estimates that by 2035, the country will need 50 metric tons per year of HALEU to support its commercial nuclear power industry, escalating to 500 metric tons per year by 2050.
About Quantum Leap Energy
Quantum Leap Energy is a development stage nuclear fuels company dedicated to advancing innovative technologies and processes across critical segments of the nuclear fuel cycle. The company focuses on both front-end activities, including uranium conversion, enrichment of uranium-235 for nuclear fuel production (HALEU, LEU+ and LEU), and isotopic separation of lithium-6 and lithium-7, as well as back-end radioactive waste treatment technologies. Through exclusive global rights to proprietary Aerodynamic Separation Process (ASP) and laser-based Quantum Enrichment (QE) technologies, Quantum Leap Energy aims to address gaps in the nuclear fuel supply chain for advanced nuclear reactors, small modular reactors, and fusion systems. The company has established strategic partnerships or commercial initiatives and relationships with industry leaders, including TerraPower, Fermi America, and the South Africa Nuclear Energy Corporation (Necsa) to accelerate the commercialization of critical isotopes essential for next-generation nuclear energy systems. For additional information, please visit: https://www.qleapenergy.com/.
About ASP Isotopes Inc.
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. ASPI employs proprietary ASP technology. ASPI’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. ASPI also plans to enrich isotopes for the nuclear energy sector using QE technology that ASPI is developing. ASPI has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes).
About NECSA
The South African Nuclear Energy Corporation (Necsa) is a state-owned public company, established by the Nuclear Energy Act in 1999. Necsa conducts nuclear research and development, supports the full nuclear value chain (including isotope production and nuclear manufacturing), and delivers industrial, medical and clean-energy applications to support South Africa’s socio-economic development. For more information, visit necsa.co.za.
Forward-Looking Statements
Statements contained herein relating to future plans, results, performance, expectations, achievements and the like are considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, the anticipated results and benefits of QLE’s collaboration with Necsa, projections about future nuclear fusion power generation technologies and enrichment methods, QLE’s anticipated growth strategies and anticipated trends in QLE’s business, statements relating to QLE’s strategic partnerships or commercial initiatives and relationships with Fermi America, TerraPower and Necsa, and statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which may be beyond QLE’s control, that may cause actual results to differ materially from any future results, performance or achievements expressed or implied by any forward-looking statements. All forward-looking statements speak only as of the date hereof. QLE and ASPI undertake no obligation to revise or update any forward-looking statements except as may be required by applicable law.
Contact
QLE@icrinc.com
FAQ**
How does the agreement between QLE SA and Necsa align with ASP Isotopes Inc.'s overall strategy for advancing their proprietary systems in the nuclear fuel production sector?
What specific infrastructure and services will Necsa provide under the Services Contract to support QLE's objectives for HALEU production, as highlighted by ASP Isotopes Inc. ASPI?
What regulatory challenges and approvals does QLE anticipate navigating while implementing this collaboration, and how might these impact ASP Isotopes Inc. ASPI's timelines?
How does the partnership with Necsa enhance ASP Isotopes Inc. ASPI's competitive positioning within the emerging HALEU market compared to other suppliers?
**MWN-AI FAQ is based on asking OpenAI questions about ASP Isotopes Inc. (NASDAQ: ASPI).
NASDAQ: ASPI
ASPI Trading
9.8% G/L:
$5.3967 Last:
4,556,706 Volume:
$5.05 Open:
